USA - New York Stock Exchange - NYSE:ENOV - US1940141062 - Common Stock
Overall ENOV gets a fundamental rating of 4 out of 10. We evaluated ENOV against 184 industry peers in the Health Care Equipment & Supplies industry. While ENOV is still in line with the averages on profitability rating, there are concerns on its financial health. ENOV scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROIC | 0.12% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Altman-Z | 0.7 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.44 | ||
| Fwd PE | 6.14 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.91 | ||
| EV/EBITDA | 8.58 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 4 / 10 to ENOV.
ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.
ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.
The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 14.57% in the next year.